RealSeq Biosciences

RealSeq Biosciences, founded with a mission to revolutionize RNA sequencing, focuses on developing advanced technologies for bias-free small RNA/miRNA NGS library construction, targeted NGS tools, and cf-RNA analysis for liquid biopsy. Their products and services cater to life science research programs and product development, aiming to provide high accuracy and efficiency in RNA sequencing. The company targets researchers and institutions in genomics and molecular biology, offering solutions that address the challenges of working with low RNA quantities.

Notable affiliates include leading scientists and researchers who have contributed to the development of RealSeq’s proprietary technologies. The company has received investment from prominent venture capital firms specializing in biotech innovations. Key achievements include the successful implementation of their technologies in various research projects, demonstrating significant improvements in data quality and complexity preservation. RealSeq Biosciences has made a substantial impact on the field of RNA sequencing, providing tools that enhance the accuracy and reliability of genomic studies.